MariMed Inc. announced that effective October 31, 2023, Susan M. Villare resigned as Chief Financial Officer of the Company. The Board of Directors has appointed Jon Levine, President and CEO, as the Company?s Interim Chief Financial Officer and has initiated a search process to identify and engage a new Chief Financial Officer.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.26 USD | -0.95% | -10.16% | -5.39% |
05-09 | Transcript : MariMed Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-08 | MariMed Inc. Provides Earning Guidance for the Full Year 2024 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.39% | 99.66M | |
+20.58% | 3.03B | |
+15.99% | 1.72B | |
+100.39% | 681M | |
+4.55% | 484M | |
+44.13% | 180M | |
+56.25% | 71.9M | |
+39.33% | 54.13M |
- Stock Market
- Equities
- MRMD Stock
- News MariMed Inc.
- MariMed Inc. Announces Executive Changes